반응식
[NH2:1][C:2]1[N:3]=[C:4]2[CH:9]=[CH:8][C:7]([O:10][C:11]3[CH:12]=[C:13]([NH:18][C:19]([C:21]4[N:25]([CH3:26])[N:24]=[C:23]([CH3:27])[CH:22]=4)=[O:20])[CH:14]=[C:15]([CH3:17])[CH:16]=3)=[CH:6][N:5]2[CH:28]=1.[CH:29]1([C:32](Cl)=[O:33])[CH2:31][CH2:30]1>CN(C)C(=O)C>[CH:29]1([C:32]([NH:1][C:2]2[N:3]=[C:4]3[CH:9]=[CH:8][C:7]([O:10][C:11]4[CH:12]=[C:13]([NH:18][C:19]([C:21]5[N:25]([CH3:26])[N:24]=[C:23]([CH3:27])[CH:22]=5)=[O:20])[CH:14]=[C:15]([CH3:17])[CH:16]=4)=[CH:6][N:5]3[CH:28]=2)=[O:33])[CH2:31][CH2:30]1참가 물질
4
반응물 2
생성물 1
시약·촉매·용매 1
실험 절차
In the same manner as in Example 9-2 and using N-{3-[(2-aminoimidazo[1,2-a]pyridin-6-yl)oxy]-5-methylphenyl}-1,3-dimethyl-1H-pyrazole-5-carboxamide (300 mg, 0.797 mmol), cyclopropanecarbonyl chloride (72.0 μL, 0.797 mmol) and N,N-dimethylacetamide (10 mL) as starting materials, the title compound (111 mg, 31%) was obtained as a pale-yellow solid.
출처 및 근거
- ORD 기록
- ord-0feab371947b4dc4a87e032d05b7e869
- 출처 데이터셋
- uspto-grants-2012_11
- 특허 번호
- US08304557B2
연결된 노트
불러오는 중…